Drug development pipelines are inundated with candidates with poor oral bioavailability. In order achieve target exposure and be efficacious, these compounds often require solubility and/or dissolution rate enhancement with an enabling technology. Many technologies exist at the disposal of drug development scientists, and the selection of which is crucial to ensure success at reasonable cost and timeline. The ultimate goal in any drug development program is to propose the simplest, most cost-effective solution for developing the targeted drug product and hinges on applying an integrated approach where bio-performance, stability and manufacture are considered throughout the development cycle. This on-demand webinar will focus on some of the key considerations for selecting and evaluating the appropriate technology for improving the oral bioavailability of poorly soluble compounds, centered around using a hypothesis driven approach to formulation.
Content Type: Webinar (on-demand)
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center